Australian Court Bars Ranbaxy's Generic Lipitor
In another blow to generic drug maker Ranbaxy Laboratories, the Australian Federal Court has upheld the exclusivity of Pfizer Inc.'s patent covering an active ingredient in anti-cholesterol drug Lipitor in Australia....To view the full article, register now.
Already a subscriber? Click here to view full article